Henry Schein, Inc. (HSIC) Return on Invested Capital (ROIC): 6.58%
Is Henry Schein, Inc.’s return on invested capital (ROIC) high or low?
Henry Schein, Inc.'s return on invested capital (ROIC) of 6.58% is 20% below its 5-year average of 8.24%, near the low end of its 5-year range (6.58%–10.99%).
As of Tuesday, June 23, 2026. 1.13% below its 12-month average of 6.66%.
HSIC Return on Invested Capital (ROIC) Chart
HSIC Average Return on Invested Capital (ROIC) Chart
HSIC Current vs Average Return on Invested Capital (ROIC) Chart
HSIC Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
6.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
6.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
7.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
8.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
9.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
9.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
9.97%
CURRENT VS TTM AVG
-1.13%
CURRENT VS 3Y AVG
-15.04%
CURRENT VS 5Y AVG
-20.13%
CURRENT VS 10Y AVG
-28.27%
CURRENT VS 15Y AVG
-32.99%
CURRENT VS 20Y AVG
-33.99%
HSIC Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Henry Schein, Inc. (HSIC) | $8.96B | 6.58% | 6.66% | 7.75% | 8.24% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 8.36% | 4.65% | 6.09% | 6.66% |
| Tempus AI, Inc. (TEM)vs › | $8.35B | -10.29% | -59.01% | -58.33% | -53.58% |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | -27.10% | -12.21% | -19.73% | -18.73% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 2.04% | 2.21% | 2.35% | 2.39% |
| Baxter International Inc. (BAX)vs › | $10.36B | -1.79% | -0.86% | -2.61% | 0.30% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -24.28% | -15.13% | -6.38% | -2.73% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 6.02% | 9.35% | -2.77% | -9.72% |
| Revvity, Inc. (RVTY)vs › | $11.05B | 2.82% | 2.97% | 3.42% | 5.50% |
| Align Technology, Inc. (ALGN)vs › | $12.44B | 9.94% | 9.96% | 10.13% | 11.66% |
Capital Efficiency
ROIC
6.6%
ROE
12.1%
Henry Schein, Inc. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Henry Schein, Inc. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Henry Schein, Inc. (HSIC)?
- The return on invested capital (ROIC) for HSIC stock is 6.58%.
- Is Henry Schein, Inc.'s return on invested capital (ROIC) high or low?
- Henry Schein, Inc.'s return on invested capital (ROIC) of 6.58% is 20% below its 5-year average of 8.24%, near the low end of its 5-year range (6.58%–10.99%).
- What is the TTM average return on invested capital (ROIC) for Henry Schein, Inc. (HSIC)?
- The TTM average return on invested capital (ROIC) for HSIC stock is 6.66%.
- What is the 3Y average return on invested capital (ROIC) for Henry Schein, Inc. (HSIC)?
- The 3Y average return on invested capital (ROIC) for HSIC stock is 7.75%.
- What is the 5Y average return on invested capital (ROIC) for Henry Schein, Inc. (HSIC)?
- The 5Y average return on invested capital (ROIC) for HSIC stock is 8.24%.
- What is the 10Y average return on invested capital (ROIC) for Henry Schein, Inc. (HSIC)?
- The 10Y average return on invested capital (ROIC) for HSIC stock is 9.17%.
- What is the 15Y average return on invested capital (ROIC) for Henry Schein, Inc. (HSIC)?
- The 15Y average return on invested capital (ROIC) for HSIC stock is 9.82%.
- What is the 20Y average return on invested capital (ROIC) for Henry Schein, Inc. (HSIC)?
- The 20Y average return on invested capital (ROIC) for HSIC stock is 9.97%.
Henry Schein, Inc. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-27 | 6.58% |
| 2024-12-28 | 6.73% |
| 2023-12-31 | 6.68% |
| 2022-12-31 | 10.99% |
| 2021-12-31 | 10.40% |
| 2020-12-31 | 8.05% |
| 2019-12-31 | 10.65% |
| 2018-12-31 | 8.97% |
| 2017-12-31 | 8.34% |
| 2016-12-31 | 11.88% |
| 2015-12-31 | 11.64% |
| 2014-12-31 | 11.02% |
| 2013-12-31 | 11.82% |
| 2012-12-31 | 11.24% |
| 2011-12-31 | 11.36% |
| 2010-12-31 | 10.75% |
| 2009-12-31 | 11.98% |
| 2008-12-31 | 11.55% |
| 2007-12-31 | 10.60% |
| 2006-12-31 | 9.28% |
| 2005-12-31 | 8.81% |
| 2004-12-31 | 8.03% |
| 2003-12-31 | 11.18% |
| 2002-12-31 | 10.80% |
| 2001-12-31 | 9.62% |
| 2000-12-31 | 8.89% |
| 1999-12-31 | 7.77% |
| 1998-12-31 | 6.21% |
| 1997-12-31 | -0.65% |
| 1996-12-31 | 4.10% |
Related Metrics
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini